A citation-based method for searching scientific literature

Margaretha M Visser, Sara Charleer, Steffen Fieuws, Christophe De Block, Robert Hilbrands, Liesbeth Van Huffel, Toon Maes, Gerd Vanhaverbeke, Eveline Dirinck, Nele Myngheer, Chris Vercammen, Frank Nobels, Bart Keymeulen, Chantal Mathieu, Pieter Gillard. Lancet 2021
Times Cited: 11







List of co-cited articles
287 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
Roy W Beck, Tonya Riddlesworth, Katrina Ruedy, Andrew Ahmann, Richard Bergenstal, Stacie Haller, Craig Kollman, Davida Kruger, Janet B McGill, William Polonsky,[...]. JAMA 2017
451
54

Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
Cornelis A J van Beers, J Hans DeVries, Susanne J Kleijer, Mark M Smits, Petronella H Geelhoed-Duijvestijn, Mark H H Kramer, Michaela Diamant, Frank J Snoek, Erik H Serné. Lancet Diabetes Endocrinol 2016
171
54

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
Tadej Battelino, Thomas Danne, Richard M Bergenstal, Stephanie A Amiel, Roy Beck, Torben Biester, Emanuele Bosi, Bruce A Buckingham, William T Cefalu, Kelly L Close,[...]. Diabetes Care 2019
734
45


Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study.
Jan Šoupal, Lenka Petruželková, George Grunberger, Aneta Hásková, Milan Flekač, Martin Matoulek, Ondřej Mikeš, Tomáš Pelcl, Jan Škrha, Eva Horová,[...]. Diabetes Care 2020
66
45

State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018.
Nicole C Foster, Roy W Beck, Kellee M Miller, Mark A Clements, Michael R Rickels, Linda A DiMeglio, David M Maahs, William V Tamborlane, Richard Bergenstal, Elizabeth Smith,[...]. Diabetes Technol Ther 2019
612
36

Improved Time in Range Over 1 Year Is Associated With Reduced Albuminuria in Individuals With Sensor-Augmented Insulin Pump-Treated Type 1 Diabetes.
Ajenthen G Ranjan, Signe V Rosenlund, Tine W Hansen, Peter Rossing, Steen Andersen, Kirsten Nørgaard. Diabetes Care 2020
19
36


Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes.
J Geddes, J E Schopman, N N Zammitt, B M Frier. Diabet Med 2008
213
36

Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.
Jan Bolinder, Ramiro Antuna, Petronella Geelhoed-Duijvestijn, Jens Kröger, Raimund Weitgasser. Lancet 2016
406
36

American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus.
George Grunberger, Jennifer Sherr, Myriam Allende, Thomas Blevins, Bruce Bode, Yehuda Handelsman, Richard Hellman, Rosemarie Lajara, Victor Lawrence Roberts, David Rodbard,[...]. Endocr Pract 2021
9
33


Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials.
Roy W Beck, Richard M Bergenstal, Tonya D Riddlesworth, Craig Kollman, Zhaomian Li, Adam S Brown, Kelly L Close. Diabetes Care 2019
226
27

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
Marcus Lind, William Polonsky, Irl B Hirsch, Tim Heise, Jan Bolinder, Sofia Dahlqvist, Erik Schwarz, Arndís Finna Ólafsdóttir, Anders Frid, Hans Wedel,[...]. JAMA 2017
292
27

Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study.
Sara Charleer, Chantal Mathieu, Frank Nobels, Christophe De Block, Regis P Radermecker, Michel P Hermans, Youri Taes, Chris Vercammen, Guy T'Sjoen, Laurent Crenier,[...]. J Clin Endocrinol Metab 2018
72
27

Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society.
Elizabeth R Seaquist, John Anderson, Belinda Childs, Philip Cryer, Samuel Dagogo-Jack, Lisa Fish, Simon R Heller, Henry Rodriguez, James Rosenzweig, Robert Vigersky. Diabetes Care 2013
796
27

Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes: The SWITCH 1 Randomized Clinical Trial.
Wendy Lane, Timothy S Bailey, Gregg Gerety, Janusz Gumprecht, Athena Philis-Tsimikas, Charlotte Thim Hansen, Thor S S Nielsen, Mark Warren. JAMA 2017
116
27

Sustained Reduction in Severe Hypoglycemia in Adults With Type 1 Diabetes Complicated by Impaired Awareness of Hypoglycemia: Two-Year Follow-up in the HypoCOMPaSS Randomized Clinical Trial.
Stuart A Little, Jane Speight, Lalantha Leelarathna, Emma Walkinshaw, Horng Kai Tan, Anita Bowes, Alexandra Lubina-Solomon, Thomas J Chadwick, Deborah D Stocken, Catherine Brennand,[...]. Diabetes Care 2018
25
27

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
Sue A Brown, Boris P Kovatchev, Dan Raghinaru, John W Lum, Bruce A Buckingham, Yogish C Kudva, Lori M Laffel, Carol J Levy, Jordan E Pinsker, R Paul Wadwa,[...]. N Engl J Med 2019
223
27

Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes: the U.K. DAFNE experience.
David Hopkins, Ian Lawrence, Peter Mansell, Gillian Thompson, Stephanie Amiel, Michael Campbell, Simon Heller. Diabetes Care 2012
145
27

The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c.
Roy W Beck, Richard M Bergenstal, Peiyao Cheng, Craig Kollman, Anders L Carlson, Mary L Johnson, David Rodbard. J Diabetes Sci Technol 2019
135
27


Glycemic characteristics in continuously monitored patients with type 1 and type 2 diabetes: normative values.
Bruce W Bode, Sherwyn Schwartz, Harrison A Stubbs, Jon E Block. Diabetes Care 2005
90
27


Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Richard E Pratley, Lauren G Kanapka, Michael R Rickels, Andrew Ahmann, Grazia Aleppo, Roy Beck, Anuj Bhargava, Bruce W Bode, Anders Carlson, Naomi S Chaytor,[...]. JAMA 2020
42
27

Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose Monitoring.
Steven V Edelman, Nicholas B Argento, Jeremy Pettus, Irl B Hirsch. Diabetes Care 2018
60
18

Practical aspects of real-time continuous glucose monitors: the experience of the Yale Children's Diabetes Program.
Brett Ives, Kristin Sikes, Andrea Urban, Kerry Stephenson, William V Tamborlane. Diabetes Educ 2010
14
18



Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials.
Maria Ida Maiorino, Simona Signoriello, Antonietta Maio, Paolo Chiodini, Giuseppe Bellastella, Lorenzo Scappaticcio, Miriam Longo, Dario Giugliano, Katherine Esposito. Diabetes Care 2020
38
18

Practical implementation, education and interpretation guidelines for continuous glucose monitoring: A French position statement.
S Borot, P Y Benhamou, C Atlan, E Bismuth, E Bonnemaison, B Catargi, G Charpentier, A Farret, N Filhol, S Franc,[...]. Diabetes Metab 2018
26
18


International Consensus on Use of Continuous Glucose Monitoring.
Thomas Danne, Revital Nimri, Tadej Battelino, Richard M Bergenstal, Kelly L Close, J Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A Amiel,[...]. Diabetes Care 2017
668
18

Real-World Evidence and Glycemic Improvement Using Dexcom G6 Features.
Halis Kaan Akturk, Robert Dowd, Kaushik Shankar, Mark Derdzinski. Diabetes Technol Ther 2021
6
33

Real-World Hypoglycemia Avoidance with a Continuous Glucose Monitoring System's Predictive Low Glucose Alert.
Sarah Puhr, Mark Derdzinski, John B Welsh, Andrew Scott Parker, Tomas Walker, David A Price. Diabetes Technol Ther 2019
23
18





Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial.
Bo Ahrén, Irl B Hirsch, Thomas R Pieber, Chantal Mathieu, Fernando Gómez-Peralta, Troels Krarup Hansen, Areti Philotheou, Sune Birch, Erik Christiansen, Thomas Jon Jensen,[...]. Diabetes Care 2016
79
18


GLP-1 receptor agonists in type 1 diabetes: a MAG1C bullet?
Michael A Nauck, Juris J Meier. Lancet Diabetes Endocrinol 2020
7
28

Changing the landscape for type 1 diabetes: the first step to prevention.
Colin M Dayan, Maria Korah, Danijela Tatovic, Brian N Bundy, Kevan C Herold. Lancet 2019
27
18

Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank.
Nicholas J Thomas, Samuel E Jones, Michael N Weedon, Beverley M Shields, Richard A Oram, Andrew T Hattersley. Lancet Diabetes Endocrinol 2018
160
18

Clinical applications of diabetes antibody testing.
Polly J Bingley. J Clin Endocrinol Metab 2010
140
18

Continuous subcutaneous insulin infusion (insulin pump) therapy can be safely used in the hospital in select patients.
Rachel M Bailon, Brenda J Partlow, Victoria Miller-Cage, Mary E Boyle, Janna C Castro, Peggy B Bourgeois, Curtiss B Cook. Endocr Pract 2009
41
18

Emerging routes to the generation of functional β-cells for diabetes mellitus cell therapy.
Gopika G Nair, Emmanuel S Tzanakakis, Matthias Hebrok. Nat Rev Endocrinol 2020
25
18

Documentation of Skin-Related Issues Associated with Continuous Glucose Monitoring Use in the Scientific Literature.
Stefan Pleus, Sina Ulbrich, Eva Zschornack, Stefanie Kamann, Cornelia Haug, Guido Freckmann. Diabetes Technol Ther 2019
17
18




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.